LiquidHub Teams with Management Science Associates (MSA) to Deliver De-Identified Patient-Level Data to Pharmaceutical Manufacturers
WAYNE, PA. – April 05, 2016 – LiquidHub, a digital transformation company providing customer engagement and technology solutions to global corporations, today announced that its Specialty Pharmaceutical data aggregation and analytics platform, LiquidAnalytics, has been integrated with Management Science Associates, Inc.’s (MSA) encryption engine to de-identify patient level data and provide advanced patient longitudinal analytics. This unique technology enables pharmaceutical manufacturers to follow the entire patient journey—without access to any patient level data—as they move through the process of gaining access to therapy.
“Data security and privacy are critical issues in the healthcare space,” said Thomas Hannigan, partner, Life Sciences at LiquidHub. “Specialty pharmacies, and other patient service providers, can be confident that LiquidAnalytics is leveraging best-in-class encryption and de-identification technology to remain compliant with HIPAA regulations and to ensure the security of their patients’ information. As pharmaceutical manufacturers increase their focus on patient centricity, this technology allows for better visibility into the patient journey, and the ability to remove barriers to getting, and keeping patients on therapy.”
Using a proprietary process certified as compliant with Health Insurance Portability and Accountability Act (HIPAA), LiquidAnalytics uses MSA technology to encrypt and apply a de-identified patient identifier. In the absence of this process, patient counts are inaccurate as movements across pharmacies appear as patient discontinuations and new starts. Identified patient level data is processed through the MSA engine on-premise at the pharmacies, providing manufacturers with a unique patient ID without the need for sharing patient data. This de-identification practice allows LiquidAnalytics to mitigate risk and streamline the process of sharing health data.
“MSA Life Sciences is proud to provide technologically advanced, trusted tools that help LiquidHub and their customers better understand patient needs,” said Tony Fontecchio, vice president, MSA Life Sciences Division. “Having the ability to de-identify and transform disparate healthcare data into anonymous, longitudinal, patient-level data supports the complex analytics and research initiatives that can ultimately help people lead healthier lives.”
To learn more about LiquidHub and the LiquidAnalytics platform, please visit www.liquidhub.com.
About Management Science Associates, Inc.
MSA creates and commercializes information-based models, processes, systems and software for industry and government. Since its inception in the 1950s, its incorporation in 1963 and through today, MSA has partnered with customers to identify areas where innovative use of data and analytic systems can create value by driving growth and/or efficiency. Using its expertise with the tools of information management – analytics, data management and software and systems technology – MSA develops, integrates, implements and maintains products and services in various functional and vertical domains. Within processes and departments, across large and small enterprises, and throughout demand and supply chains, MSA helps customers put their data to work.
MSA’s 800+ employees provide solutions for over 300 clients, including some of the largest and most innovative U.S. and foreign corporations and institutions. Headquartered in Pittsburgh, PA, MSA also has offices in New York City; Atlanta; Cardiff, UK; Shanghai and Beijing, China; and Kuala Lumpur, Malaysia. It also maintains a presence in High Point, NC; Florida and Las Vegas. For more information about MSA, please visit www.MSA.com.
LiquidHub is a digital integrator partners with businesses to improve customer engagement and drive growth. With operations in North America, Asia, and Europe, we empower the leading companies by delivering superior user experience and technology enablement.
LiquidHub’s Life Sciences Practice has vast experience with specialty data aggregation. We deploy our modern cloud-based Specialty data management platform (LiquidAnalytics) that accelerates implementations while reducing risk. We deliver meaningful analytics through our cloud-based reporting platform, and maintain high quality data through our automated data quality rules engine. LiquidHub is currently supporting over 30 brands across multiple therapeutic areas including MS, Hemophilia, Oncology, Cystic Fibrosis, RA, and other conditions.